Intellectual Property Cases
Cases 31 - 40 of 190
Valeant Pharmaceuticals North America LLC et al v. PAR Pharmaceutical, Inc.
as 1:2018cv08221
Plaintiff: Dow Pharmaceutical Sciences, Inc., Valeant Pharmaceuticals Ireland Ltd., Kaken Pharmaceutical Co., Ltd. and others
Defendant: PAR Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271
VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. PAR PHARMACEUTICAL, INC.
as 3:2018cv13701
Plaintiff: DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD., KAKEN PHARMACEUTICAL CO., LTD. and others
Defendant: PAR PHARMACEUTICAL, INC.
Cause Of Action: 35 U.S.C. § 271
Athenex Pharma Solutions, LLC et al v. Par Pharmaceutical, Inc. et al
as 1:2018cv00896
Plaintiff: Athenex Pharmaceutical Division, LLC and Athenex Pharma Solutions, LLC
Defendant: Par Sterile Products, LLC, Endo Par Innovation Company, LLC and Par Pharmaceutical, Inc.
Cause Of Action: 28 U.S.C. § 2201
Horizon Therapeutics, LLC v. Par Pharmaceuticals, Inc. et al
as 1:2018cv01224
Defendant: Par Pharmaceutical Companies, Inc. and Par Pharmaceuticals, Inc.
Plaintiff: Horizon Therapeutics, LLC
Cause Of Action: 35 U.S.C. § 271
Shire-NPS Pharmaceuticals, Inc. v. Par Pharmaceutical Companies, Inc. et al
as 1:2018cv01115
Defendant: Par Pharmaceutical Companies, Inc., Par Sterile Products, LLC and Par Pharmaceutical, Inc.
Plaintiff: Shire-NPS Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al We have downloadable decisions or orders for this case
as 1:2018cv01043
Defendant: Emcure Pharmaceuticals, Torrent Pharmaceuticals Ltd., Mylan Pharmaceuticals, Inc. and others
Counter Claimant: Biocon Limited, HEC Pharm Group, HEC Pharm Co., Ltd. and others
Counter Defendant: Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Par Pharmaceutical, Inc. et al v. Eagle Pharmaceuticals, Inc. We have downloadable decisions or orders for this case
as 1:2018cv00823
Defendant: Eagle Pharmaceuticals, Inc.
Plaintiff: Par Sterile Products, LLC, Par Pharmaceutical, Inc. and Endo Par Innovation Company, LLC
Cause Of Action: 35 U.S.C. § 271
INDIVIOR INC. et al v. PAR PHARMACEUTICAL, INC. et al
as 2:2018cv05293
Plaintiff: INDIVIOR INC. , INDIVIOR UK LIMITED and AQUESTIVE THERAPEUTICS, INC.
Defendant: PAR PHARMACEUTICAL, INC., PAR PHARMACEUTICAL COMPANIES INC. and ENDO INTERNATIONAL PLC
Cause Of Action: 15 U.S.C. § 1126
Sumitomo Dainippon Pharma Co., Ltd. et al v. Par Pharmaceutical, Inc.
as 1:2018cv02107
Plaintiff: Sumitomo Dainippon Pharma Co., Ltd. and Sunovion Pharmaceuticals Inc.
Defendant: Par Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271
SUMITOMO DAINIPPON PHARMA CO., LTD. et al v. AUROBINDO PHARMA LTD. et al
as 2:2018cv02620
Plaintiff: SUMITOMO DAINIPPON PHARMA CO., LTD. and SUNOVION PHARMACEUTICALS INC.
Defendant: AUROBINDO PHARMA LTD., DR. REDDY'S LABORATORIES, LTD., DR. REDDY'S LABORATORIES, INC. and others
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?